| Trial ID: | L0553 |
| Source ID: | NCT01820832
|
| Associated Drug: |
Calcitriol
|
| Title: |
Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Proteinuria
|
| Interventions: |
DRUG: Calcitriol
|
| Outcome Measures: |
Primary: the percentage change of proteinuia, 24 weeks | Secondary: the proportion of patients achieving at least a 15% decrease in proteinuria, 24 weeks | Other: mean change of renal function (serum creatine, cystatin C, eGFR), 24 weeks|blood pressure, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Huashan Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-03
|
| Completion Date: |
2015-06
|
| Results First Posted: |
|
| Last Update Posted: |
2013-03-29
|
| Locations: |
Huashan Hospital, Fudan University, Shanghai, Shanghai, 200040, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01820832
|
